CIK 0001070081 · Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043416587
- Phone
- 9082227000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,752,145
- in 10 filings, $7.8M under 10b5-1 plans
Net −$7,752,145. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,356 | 33,806 | ||
| 2025-09-11 | Boulding Mark Elliott EXEC. VP AND CLO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,470 | 31,336 | ||
| 2025-09-09 | SOUTHWELL DAVID P Director | Option exercise | +12,000 | $30.86 | $370K | 28,850 |
| 2025-09-09 | SOUTHWELL DAVID P Director | Sale | −12,000 | $58.34 | $700K | 16,850 |
| 2025-09-09 | SOUTHWELL DAVID P Director | Option exercise · Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +16,698 | $30.86 | $515K | 89,610 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −16,698 | $56.94 | $951K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +6,017 | $11.23 | $68K | 78,929 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −6,017 | $56.91 | $342K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +8,528 | $18.01 | $154K | 81,440 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −8,528 | $56.92 | $485K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +3,713 | $30.86 | $115K | 76,625 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −3,713 | $56.92 | $211K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +2,406 | $11.23 | $27K | 75,318 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −2,406 | $56.92 | $137K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +1,238 | $11.32 | $14K | 74,150 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,238 | $56.85 | $70K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +1,250 | $11.32 | $14K | 74,162 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale 10b5-1 | −1,250 | $56.86 | $71K | 72,912 |
| 2025-09-08 | Pauwels Eric CHIEF BUSINESS OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,698 | 3,713 |
Page 24 of 25 · 493 trades